Long Noncoding RNAs: Clarity or Confusion?
Because They Are Such Elusive Prey, lncRNAs Have Yet to Emerge as Therapeutic Targets
Markets Expand for Single-Use Bioreactors
Biobags Offer Advantages Over Fixed-Tank Systems
The Challenges of Harmonizing Biomarker Data
Why Trial Success Depends on It
Top 10 Wall Street Losers of 2016
These Companies Lost the Most in a Down Year for Biopharma Stocks
- Swift Biosciences
- 58 Parkland Plaza
- Suite 100
- Ann Arbor MI, 48103
- UNITED STATES
Swift Biosciences makes products that detect genes and gene products and also helps users analyze samples. Swift Biosciences opened its doors in February 2010 and launched the first retail product in its myT™ Primers platform—myT™ BRAF—for detection of BRAF mutations in February of 2012.